Keywords: basf, pharma, sales, driving, growth, german, pharmaceuticals
BASF Pharma Sales Driving Growth
Article | 12 November 1998
German pharmaceuticals and chemicals group BASF had pretax profits forthe third quarter of 1998 of 1.49 billion Deutschemarks ($882.5 million), a rise of 13.2%, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
